Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Teva Pharmaceutical Industries Limited TEVA

Full chart Compare
Set alert

Price alert · TEVA

All alert types
41.91 USD +1.21 (+2.97%)

At closeNov 3, 2026, 6:20 PM EST

41.90 -0.01 -0.02%

After hours · Nov 3, 6:20 PM ET

41.54 Day range 43.34
20.11 52-week range 43.34
YTD
+34.28%
1 year
+104.24%

Financial health

Altman Z-Score

2.24 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 25.4×
FY 2016: 518×FY 2017: -1.2×FY 2018: -7.3×FY 2019: -10.7×FY 2020: -2.7×FY 2021: 21.1×FY 2022: -4.1×FY 2023: -20.9×FY 2024: -15.2×FY 2025: 25.4×
FY 2016 5y median -4.1× FY 2025
P/S 2.1×
FY 2016: 1.6×FY 2017: 0.9×FY 2018: 0.8×FY 2019: 0.6×FY 2020: 0.6×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 1.5×FY 2025: 2.1×
FY 2016 5y median 0.7× FY 2025
P/B 4.5×
FY 2016: 1.0×FY 2017: 1.1×FY 2018: 1.1×FY 2019: 0.8×FY 2020: 1.1×FY 2021: 0.9×FY 2022: 1.3×FY 2023: 1.6×FY 2024: 4.6×FY 2025: 4.5×
FY 2016 5y median 1.6× FY 2025
P/FCF 31.2×
FY 2016: 8.0×FY 2017: 7.3×FY 2018: 8.8×FY 2019: 25.5×FY 2020: 16.6×FY 2021: 37.4×FY 2022: 9.7×FY 2023: 13.9×FY 2024: 33.3×FY 2025: 31.2×
FY 2016 5y median 31.2× FY 2025
EV/EBITDA 15.8×
FY 2016: 24.0×FY 2017: -3.3×FY 2018: 231×FY 2019: 8.1×FY 2020: 7.5×FY 2021: 6.8×FY 2022: -31.2×FY 2023: 18.4×FY 2024: 9.0×FY 2025: 15.8×
FY 2016 5y median 9.0× FY 2025
EV/Sales 2.9×
FY 2016: 3.2×FY 2017: 2.3×FY 2018: 2.3×FY 2019: 2.1×FY 2020: 2.1×FY 2021: 1.9×FY 2022: 1.9×FY 2023: 1.8×FY 2024: 2.4×FY 2025: 2.9×
FY 2016 5y median 1.9× FY 2025
FCF Yield 3.2%
FY 2016: 12.5%FY 2017: 13.7%FY 2018: 11.4%FY 2019: 3.9%FY 2020: 6.0%FY 2021: 2.7%FY 2022: 10.3%FY 2023: 7.2%FY 2024: 3.0%FY 2025: 3.2%
FY 2016 5y median 3.2% FY 2025

Profitability

Gross Margin 51.8%
FY 2016: 54.1%FY 2017: 48.4%FY 2018: 44.0%FY 2019: 44.6%FY 2020: 46.4%FY 2021: 47.8%FY 2022: 46.7%FY 2023: 48.2%FY 2024: 48.7%FY 2025: 51.8%
FY 2016 5y median 48.2% FY 2025
Operating Margin 12.5%
FY 2016: 9.8%FY 2017: -78.1%FY 2018: -8.7%FY 2019: -2.6%FY 2020: -21.4%FY 2021: 10.8%FY 2022: -14.7%FY 2023: 2.7%FY 2024: -1.8%FY 2025: 12.5%
FY 2016 5y median 2.7% FY 2025
Net Margin 8.2%
FY 2016: 1.5%FY 2017: -72.7%FY 2018: -11.4%FY 2019: -5.9%FY 2020: -24.0%FY 2021: 2.6%FY 2022: -16.4%FY 2023: -3.5%FY 2024: -9.9%FY 2025: 8.2%
FY 2016 5y median -3.5% FY 2025
ROE 17.8%
FY 2016: 1.0%FY 2017: -93.7%FY 2018: -14.6%FY 2019: -7.2%FY 2020: -39.8%FY 2021: 4.1%FY 2022: -31.3%FY 2023: -7.4%FY 2024: -30.5%FY 2025: 17.8%
FY 2016 5y median -7.4% FY 2025
ROIC 7.4%
FY 2016: 1.0%FY 2017: -27.8%FY 2018: -3.1%FY 2019: -1.0%FY 2020: -8.8%FY 2021: 3.1%FY 2022: -5.0%FY 2023: 1.3%FY 2024: -1.1%FY 2025: 7.4%
FY 2016 5y median 1.3% FY 2025
ROA 3.5%
FY 2016: 0.4%FY 2017: -23.0%FY 2018: -3.5%FY 2019: -1.7%FY 2020: -7.9%FY 2021: 0.9%FY 2022: -5.6%FY 2023: -1.3%FY 2024: -4.2%FY 2025: 3.5%
FY 2016 5y median -1.3% FY 2025

Growth (YoY)

Revenue 4.3%
FY 2016: 11.5%FY 2017: 2.2%FY 2018: -15.8%FY 2019: -10.4%FY 2020: -1.4%FY 2021: -4.7%FY 2022: -6.0%FY 2023: 6.2%FY 2024: 4.4%FY 2025: 4.3%
FY 2016 FY 2025
Operating Income 811.9%
FY 2016: -35.7%FY 2017: -911.7%FY 2018: 90.6%FY 2019: 72.9%FY 2020: -706.3%FY 2021: 148.0%FY 2022: -228.0%FY 2023: 119.7%FY 2024: -170.0%FY 2025: 811.9%
FY 2016 FY 2025
EPS (diluted) 182.8%
FY 2016: -96.2%FY 2017: -22971.4%FY 2018: 86.8%FY 2019: 56.4%FY 2020: -295.7%FY 2021: 110.4%FY 2022: -678.9%FY 2023: 77.3%FY 2024: -190.0%FY 2025: 182.8%
FY 2016 FY 2025
Free Cash Flow 53.3%
FY 2016: -9.4%FY 2017: -39.1%FY 2018: -31.8%FY 2019: -76.7%FY 2020: 52.3%FY 2021: -63.0%FY 2022: 341.5%FY 2023: -19.2%FY 2024: -11.0%FY 2025: 53.3%
FY 2016 FY 2025

Financial Health

Current Ratio 1.0×
FY 2016: 0.9×FY 2017: 0.9×FY 2018: 1.0×FY 2019: 1.0×FY 2020: 1.0×FY 2021: 1.1×FY 2022: 1.1×FY 2023: 1.0×FY 2024: 1.0×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Quick Ratio 0.8×
FY 2016: 0.6×FY 2017: 0.6×FY 2018: 0.6×FY 2019: 0.7×FY 2020: 0.7×FY 2021: 0.8×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 0.8×
FY 2016 5y median 0.7× FY 2025
Debt / Equity 2.2×
FY 2016: 1.1×FY 2017: 1.9×FY 2018: 2.0×FY 2019: 2.0×FY 2020: 2.6×FY 2021: 2.3×FY 2022: 2.8×FY 2023: 2.7×FY 2024: 3.4×FY 2025: 2.2×
FY 2016 5y median 2.7× FY 2025
Net Debt / EBITDA 4.4×
FY 2016: 12.0×FY 2017: -2.0×FY 2018: 146×FY 2019: 5.7×FY 2020: 5.3×FY 2021: 4.8×FY 2022: -20.3×FY 2023: 10.9×FY 2024: 3.3×FY 2025: 4.4×
FY 2016 5y median 4.4× FY 2025
Interest Coverage 2.4×
FY 2016: 1.6×FY 2017: -19.5×FY 2018: -1.9×FY 2019: -0.5×FY 2020: -4.7×FY 2021: 1.9×FY 2022: -2.4×FY 2023: 0.4×FY 2024: -0.3×FY 2025: 2.4×
FY 2016 5y median 0.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 4.5%FY 2017: 6.0%FY 2018: 0.1%FY 2019: 0.5%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 473.6%FY 2017: -7.1%FY 2018: -1.0%FY 2019: -5.2%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31